Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
383. Dews never has heard of<br />
James K. Dews<br />
Bio*Shark. (R19 (Dews, Dep. at 53)).<br />
384. Dews is not familar with the use of shark carilage in the treatment of cancer, and he has<br />
never seen any data relating to the use of shark carilage in the treatment of cancer. He<br />
only has heard ofthis. (R19 (Dews, Dep. at 54)).<br />
Sallv B. LaMont. N.D.<br />
385. LaMont does not know whether the product Bio*Shark inbits tuor growt. (R22<br />
(LaMont, Dep. at 91)).<br />
386. LaMont does not know whether Bio*Shark is effective in the prevention, treatment, or<br />
cure of cancer. (R22 (LaMont, Dep. at 92); LaMont, Tr. 580).<br />
387. LaMont acknowledged that there are no well-controlled studies demonstratig that the<br />
product Bio*Shark is anti angiogenc. (R22 (LaMont, Dep. at 101)).<br />
388. LaMont stated that there are no studies on Bio*Shark that are controlled clincal trals<br />
demonstrating its effectiveness. (R22 (LaMont, Dep. at 101)).<br />
389. LaMont does not know of any good or reliable data on the amount of anti<br />
activity per gram of shark carilage. (R22 (LaMont, Dep. at 112)).<br />
angiogenic<br />
390. LaMont agreed that it would be ideal to study varables such as the bioavailabilty, the<br />
*<br />
absorption, and the distrbution of Bio Shark in order to assess its effectiveness with<br />
respect to cancer. (R22 (LaMont, Dep. at 101-102)).<br />
391. LaMont probably would not use Bio*Shark or a product like it in her practice because<br />
she ths that there are other ways to inbit angiogenesis that are more cerai. (R22<br />
(LaMont, Dep. at 151)).<br />
7 Herb Formula<br />
James Duke. Ph.D.<br />
392. Duke has no idea how much Burdock root in vitro would be necessar to elimate<br />
cancer. (R18 (Duke, Dep. at 72); Duke, Tr. 528).<br />
s in 7 Herb Formula are the "Essiac formula (that)<br />
have had both positive and negative trals published in PubMed." (R18 (Duke, Dep. at<br />
73)).<br />
393. Duke understands that four of the herb<br />
the elements that are in 7 Herb Formula are actually in<br />
the product sold by DCO. (R18 (Duke, Dep. at 78); Duke, Tr. 528).<br />
394. Duke does not know how much of<br />
395. Duke acknowledged that although two ofthe lignans in Burdock have shown<br />
antilymphomic properies, they probably were in vitro. (R18 (Duke, Dep. at 125)).<br />
34
Change language